Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cost-effectiveness of modified diagnostic strategy to safely rule-out pulmonary embolism in the emergency department: a non-inferiority cluster crossover randomized trial (MODIGLIA-NI).

Autor: Nze Ossima A; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France., Ngaleu Siaha BF; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France., Mimouni M; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France., Mezaour N; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France., Darlington M; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France., Berard L; Département de Pharmacologie Clinique and Plateforme de Recherche Clinique de l'Est Parisien, URCEST-CRC-CRB), Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital St Antoine, Paris, France., Cachanado M; Département de Pharmacologie Clinique and Plateforme de Recherche Clinique de l'Est Parisien, URCEST-CRC-CRB), Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital St Antoine, Paris, France., Simon T; Département de Pharmacologie Clinique and Plateforme de Recherche Clinique de l'Est Parisien, URCEST-CRC-CRB), Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital St Antoine, Paris, France., Freund Y; Service des Urgences, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France., Durand-Zaleski I; Paris Health Economics and Health Services Research Unit, URC Eco IdF, AP-HP, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, 75004, France. Isabelle.durand-zaleski@aphp.fr.; URCEco Hôpital de l'Hôtel Dieu, Paris, F-75004, France. Isabelle.durand-zaleski@aphp.fr.

Publikováno v: BMC emergency medicine [BMC Emerg Med] 2023 Nov 29; Vol. 23 (1), pp. 140. Date of Electronic Publication: 2023 Nov 29.

Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.

Autor: Darlington M; DRCI‑URC Eco Ile‑de‑France, Assistance Publique-Hôpitaux de Paris (AP-HP), France., Sujobert P; Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique, France., Kosmider O; Hôpital Cochin, Hématologie Biologique, AP-HP, Université, Paris Cité, France., Luque Paz D; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, France., Kaltenbach S; Hématologie Biologique, AP-HP, Necker-Enfants Malades Hospital, Paris, France., Figeac M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, France.; CHU de Lille, Equipe bioinfo du Plateau Commun de Biologie Moléculaire, Lille, France., Hayette S; Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique, France., Mezaour N; DRCI‑URC Eco Ile‑de‑France, Assistance Publique-Hôpitaux de Paris (AP-HP), France., Coquerelle S; DRCI‑URC Eco Ile‑de‑France, Assistance Publique-Hôpitaux de Paris (AP-HP), France., Alary AS; Hôpital Cochin, Hématologie Biologique, AP-HP, Université, Paris Cité, France., Bidet A; Department of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France., Le Bris Y; Hématologie Biologique, Nantes University Hospital and CRCI2NA Nantes-Angers, France., Delabesse E; Hématologie Biologique, CHU Toulouse, Inserm 1037, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, France., Davi F; AP-HP, Hôpital Pitié-Salpêtrière, Department of Biological Hematology, Sorbonne University, Paris., Preudhomme C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, France., Durand-Zaleski I; DRCI‑URC Eco Ile‑de‑France, Assistance Publique-Hôpitaux de Paris (AP-HP), France., Macintyre E; Hématologie Biologique, AP-HP, Necker-Enfants Malades Hospital, Paris, France.; Université Paris Cité, CNRS, Inserm, France.

Publikováno v: HemaSphere [Hemasphere] 2023 Aug 24; Vol. 7 (9), pp. e943. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

A systematic review of decrementally cost-effective health technologies and case studies

Autor: Scarica, R., Chavez Pacheco, X., K. Dupont, JC, Rochaix, L., Durand Zaleski, I, Darlington, M.

Background: HTA guidance has been mostly driven by situations where innovative and usually more expensive technologies are compared to the prevailing standards of care. Cheaper and less effective interventions have usually received scarce attention,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26aac8b811b8ff2d5d03481bdc3bd05d

Decrementally cost-effective health technologies in non-inferiority studies: A systematic review.

Autor: Darlington M; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France., Scarica R; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France., Chavez-Pacheco X; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France., Blamplain Segar L; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France., Durand-Zaleski I; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France.; Université de Paris Est Creteil INSERM UMRS, Paris, France.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Dec 05; Vol. 13, pp. 1025326. Date of Electronic Publication: 2022 Dec 05 (Print Publication: 2022).